A second potential COVID-19 vaccine has entered Phase 1 clinical human testing after the U.S. Food and Drug Administration (FDA) accepted an application from Inovio Pharmaceuticals. “Inovio plans to inject its first volunteer test subject with the INO-4800 DNA vaccine candidate it has developed, following promising results from preclinical studies performed on animals that did […]
[Source: www.dailywire.com] [ Comments ] [See why this is trending]